|
Volumn 3, Issue 3, 2001, Pages 37-43
|
Generalized anxiety disorder
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPRAZOLAM;
ANTICONVULSIVE AGENT;
ANTIDEPRESSANT AGENT;
ANTIHISTAMINIC AGENT;
BARBITURIC ACID DERIVATIVE;
BENZODIAZEPINE;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
BUSPIRONE;
CHLORDIAZEPOXIDE;
CHLORPROMAZINE;
CLONAZEPAM;
CLORAZEPATE;
CLORAZEPATE DIPOTASSIUM;
DIAZEPAM;
GABAPENTIN;
HALOPERIDOL;
LAMOTRIGINE;
LORAZEPAM;
MEPROBAMATE;
MONOAMINE OXIDASE INHIBITOR;
NEUROLEPTIC AGENT;
OLANZAPINE;
OXAZEPAM;
PAROXETINE;
RISPERIDONE;
SEROTONIN UPTAKE INHIBITOR;
THIORIDAZINE;
TOPIRAMATE;
UNINDEXED DRUG;
VALPROIC ACID;
VENLAFAXINE;
ANXIETY;
ANXIETY NEUROSIS;
ARTICLE;
BEHAVIOR THERAPY;
COGNITIVE DEFECT;
COGNITIVE THERAPY;
DISEASE SEVERITY;
DROWSINESS;
DRUG HALF LIFE;
DRUG METABOLISM;
EXTRAPYRAMIDAL SYMPTOM;
GENERAL PRACTICE;
HUMAN;
HYPERTENSION;
MEDICAL LITERATURE;
MEDICAL SOCIETY;
MENTAL DISEASE;
MOTOR COORDINATION;
NAUSEA;
PANIC;
PRIMARY MEDICAL CARE;
PSYCHIATRIST;
PUBLICATION;
SEXUAL DYSFUNCTION;
SIDE EFFECT;
SYMPTOM;
TARDIVE DYSKINESIA;
VOMITING;
WEIGHT GAIN;
|
EID: 0035041460
PISSN: 10983597
EISSN: None
Source Type: Journal
DOI: 10.1016/S1098-3597(01)90060-2 Document Type: Article |
Times cited : (12)
|
References (11)
|